Chimeric Capsid Protein as a Nanocarrier for siRNA Delivery: Stability and Cellular Uptake of Encapsulated siRNA
Source abstract
Abstract
For the efficient cytoplasmic delivery of siRNA, we designed a chimeric capsid protein composed of a capsid shell, integrin targeting peptide, and p19 RNA binding protein. This recombinant protein assembled into a macromolecular container-like structure with capsid shell and provided a nanocarrier for siRNA delivery. Our capsid nanocarriers had dual affinity both for siRNA within the interior and integin receptors on the exterior, and the capsid shell structure allowed the encapsulated siRNAs to be protected from the external nucleases, leading to the enhanced stability of siRNA in serum conditions. The capsid nanocarriers could complex with siRNA in a size-dependent and sequence-independent manner and showed the pH-dependent complexing/dissocation behaviors with siRNA. Moreover, RGD peptides on the exterior surface of the capsid shell enabled the capsid nanocarriers to deliver siRNA into the cytosol of the target cells. Here, we demonstrated the superior efficiency of our siRNA/capsid nanocarrier complexes in RFP gene silencing, compared to untreated cells. These results provide an alternative approach to enhancing the stability of siRNA as well as to achieving targeted siRNA delivery.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques · Virus-based gene therapy research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Center for Theragnosis, Biomedical Research Institute, Korea Institute of Science and Technology, Seongbuk-Gu, Seoul 136-791, South Korea,
Department of Biochemistry and Cell Biology, Cell and Matrix Research Institute, School of Medicine, Kyungpook National University, Daegu 700-422, South Korea.
References (45)
Show source-provided references
1. Dykxhoorn D. M. · Annu. Rev. Biomed. Eng. · 2006 · 8 · 37710.1146/annurev.bioeng.8.061505.095848 ↗
2. Martinez J. · Cell · 2002 · 110 · 56310.1016/S0092-8674(02)00908-X ↗
3. Elbashir S. M. · Nature · 2001 · 411 · 49410.1038/35078107 ↗
4. Iorns E. · Nat. Rev. Drug Discovery · 2007 · 6 · 55610.1038/nrd2355 ↗
5. Lu P. Y. · Adv. Genet. · 2005 · 54 · 117
6. Oishi M. · J. Am. Chem. Soc. · 2005 · 127 · 162410.1021/ja044941d ↗
7. Shim M. S. · FEBS J. · 2010 · 277 · 481410.1111/j.1742-4658.2010.07904.x ↗
8. Brummelkamp T. R. · Cancer Cell · 2002 · 2 · 24310.1016/S1535-6108(02)00122-8 ↗
9. Zhang S. · J. Controlled Release · 2007 · 123 · 110.1016/j.jconrel.2007.07.016 ↗
10. Sabbioni S. · Gene Ther. · 2007 · 14 · 45910.1038/sj.gt.3302878 ↗
11. Makinen P. I. · J. Gene Med. · 2006 · 8 · 43310.1002/jgm.860 ↗
12. Wadhwa R. · Curr. Opin. Mol. Ther. · 2004 · 6 · 367
13. Tomaini R. · Curr. Gene Ther. · 2004 · 4 · 35710.2174/1566523043346011 ↗
14. Devroe E. · Expert Opin. Biol. Ther. · 2004 · 4 · 31910.1517/14712598.4.3.319 ↗
15. Layzer J. M. · RNA · 2004 · 10 · 76610.1261/rna.5239604 ↗
16. Zhang S. · J. Controlled Release · 2007 · 123 · 110.1016/j.jconrel.2007.07.016 ↗
17. Tan P. H. · Gene Ther. · 2005 · 12 · 5910.1038/sj.gt.3302376 ↗
18. Thomas M. · Proc. Natl. Acad. Sci. U.S.A. · 2005 · 102 · 567910.1073/pnas.0502067102 ↗
19. Watanabe K. · Mol. BioSyst. · 2009 · 5 · 130610.1039/b900880b ↗
20. Vangasseri D. P. · Curr. Drug Delivery · 2005 · 2 · 40110.2174/156720105774370168 ↗
21. Choi Y. S. · Biomaterials · 2010 · 31 · 142910.1016/j.biomaterials.2009.11.001 ↗
22. Akhtar S. · J. Clin. Invest. · 2007 · 117 · 362310.1172/JCI33494 ↗
23. Park T. G. · Adv. Drug Delivery Rev. · 2006 · 58 · 46710.1016/j.addr.2006.03.007 ↗
24. Moghimi S. M. · Mol. Ther. · 2005 · 11 · 99010.1016/j.ymthe.2005.02.010 ↗
25. Symonds P. · FEBS Lett. · 2005 · 579 · 619110.1016/j.febslet.2005.09.092 ↗
26. Chiu Y. L. · RNA · 2003 · 9 · 103410.1261/rna.5103703 ↗
27. Czauderna F. · Nucleic Acids Res. · 2003 · 31 · 270510.1093/nar/gkg393 ↗
28. Hall A. H. · Nucleic Acids Res. · 2004 · 32 · 599110.1093/nar/gkh936 ↗
29. Schiffelers R. M. · Nucleic Acids Res. · 2004 · 32 · e14910.1093/nar/gnh140 ↗
30. Bottcher B. · Nature · 1997 · 386 · 8810.1038/386088a0 ↗
31. Park J. S. · Nat. Nanotechnol. · 2009 · 4 · 25910.1038/nnano.2009.38 ↗
32. Vargason J. M. · Cell · 2003 · 115 · 79910.1016/S0092-8674(03)00984-X ↗
33. Ye K. · Nature · 2003 · 426 · 87410.1038/nature02213 ↗
34. Crowther R. A. · Cell · 1994 · 77 · 94310.1016/0092-8674(94)90142-2 ↗
35. Whitehead K. A. · Nat. Rev. Drug Discovery · 2009 · 8 · 12910.1038/nrd2742 ↗
36. Putnam D. · Proc. Natl. Acad. Sci. U.S.A. · 2001 · 98 · 120010.1073/pnas.98.3.1200 ↗
37. Khalil I. A. · Pharmacol. Rev. · 2006 · 58 · 3210.1124/pr.58.1.8 ↗
38. Johannes L. · 2002 · 3 · 443
39. Cooper A. · Biochem. Biophys. Res. Commun. · 2005 · 327 · 109410.1016/j.bbrc.2004.12.118 ↗
40. Urban A. · Nucleic Acids Res. · 1997 · 25 · 222710.1093/nar/25.11.2227 ↗
41. Laemmli U. K. · Nature · 1970 · 227 · 68010.1038/227680a0 ↗
42. Bradford M. M. · Anal. Biochem. · 1976 · 72 · 24810.1016/0003-2697(76)90527-3 ↗
43. Wang L. H. · J. Cell Biol. · 1993 · 123 · 110710.1083/jcb.123.5.1107 ↗
44. Lanaze C. · Curr. Opin. Cell Biol. · 1995 · 7 · 57310.1016/0955-0674(95)80015-8 ↗
45. Hewlett L. J. · J. Cell Biol. · 1994 · 124 · 68910.1083/jcb.124.5.689 ↗